Sullivan Eddie Joe 4
4 · SAB Biotherapeutics, Inc. · Filed Dec 8, 2023
Insider Transaction Report
Form 4
Sullivan Eddie Joe
DirectorPRESIDENT
Transactions
- Purchase
Common Stock
2023-12-07$0.88/sh+1,740$1,531→ 5,232,304 total
Footnotes (1)
- [F1]Represents 1,740 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.